66 research outputs found

    Continuous-flow IRMS technique for determining the 17O excess of CO2 using complete oxygen isotope exchange with cerium oxide

    Get PDF
    This paper presents an analytical system for analysis of all single substituted isotopologues (<sup>12</sup>C<sup>16</sup>O<sup>17</sup>O, <sup>12</sup>C<sup>16</sup>O<sup>18</sup>O, <sup>13</sup>C<sup>16</sup>O<sup>16</sup>O) in nanomolar quantities of CO<sub>2</sub> extracted from stratospheric air samples. CO<sub>2</sub> is separated from bulk air by gas chromatography and CO<sub>2</sub> isotope ratio measurements (ion masses 45 / 44 and 46 / 44) are performed using isotope ratio mass spectrometry (IRMS). The <sup>17</sup>O excess (Δ<sup>17</sup>O) is derived from isotope measurements on two different CO<sub>2</sub> aliquots: unmodified CO<sub>2</sub> and CO<sub>2</sub> after complete oxygen isotope exchange with cerium oxide (CeO<sub>2</sub>) at 700 °C. Thus, a single measurement of Δ<sup>17</sup>O requires two injections of 1 mL of air with a CO<sub>2</sub> mole fraction of 390 μmol mol<sup>−1</sup> at 293 K and 1 bar pressure (corresponding to 16 nmol CO<sub>2</sub> each). The required sample size (including flushing) is 2.7 mL of air. A single analysis (one pair of injections) takes 15 minutes. The analytical system is fully automated for unattended measurements over several days. The standard deviation of the <sup>17</sup>O excess analysis is 1.7&permil;. Multiple measurements on an air sample reduce the measurement uncertainty, as expected for the statistical standard error. Thus, the uncertainty for a group of 10 measurements is 0.58&permil; for &Delta; <sup>17</sup>O in 2.5 h of analysis. 100 repeat analyses of one air sample decrease the standard error to 0.20&permil;. The instrument performance was demonstrated by measuring CO<sub>2</sub> on stratospheric air samples obtained during the EU project RECONCILE with the high-altitude aircraft Geophysica. The precision for RECONCILE data is 0.03&permil; (1&sigma;) for δ<sup>13</sup>C, 0.07&permil; (1&sigma;) for δ<sup>18</sup>O and 0.55&permil; (1&sigma;) for &delta;<sup>17</sup>O for a sample of 10 measurements. This is sufficient to examine stratospheric enrichments, which at altitude 33 km go up to 12&permil; for &delta;<sup>17</sup>O and up to 8&permil; for δ<sup>18</sup>O with respect to tropospheric CO<sub>2</sub> : &delta;<sup>17</sup>O ~ 21&permil; Vienna Standard Mean Ocean Water (VSMOW), δ<sup>18</sup>O ~ 41&permil; VSMOW (Lämmerzahl et al., 2002). The samples measured with our analytical technique agree with available data for stratospheric CO<sub>2</sub>

    Microenvironment involved in FPR1 expression by human glioblastomas

    Get PDF
    Formyl peptide receptor 1 (FPR1) activity in U87 glioblastoma (GBM) cells contributes to tumor cell motility. The present study aimed to evaluate the FPR1 expression in human GBM, the possibility to elicit agonist induced FPR1 activation of GBM cells and inhibit this activation with chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS). Immunohistochemistry was used to assess FPR1 expression in GBM patient samples, which was present in all 178 samples. Also FPR1 mRNA levels measured with quantitative PCR, could be detected in all 25 GBM patient samples tested. Activation of FPR1 in U87 cells, as measured by human mitochondrial-derived agonists, increased calcium mobilization, AKT and ERK1/2 phosphorylation, and ligand-induced migration. Inhibition of all responses could be achieved with CHIPS. Eight early passage human Groningen Glioma (GG) cell lines, isolated from primary GBM tissue were screened for the presence of FPR1. FPR1 mRNA and protein expression as well as receptor activation could not be detected in any of these early passage GG cell lines. However FPR1 was present in ex vivo tumors formed by the same GG cell lines after being implanted in mouse brains. FPR1 is highly expressed in human GBM specimens, it can be activated by human mitochondrial-derived agonists in U87 and inhibited with CHIPS. FPR1 cannot be detected in early passage GG cell lines in vitro, however when engrafted in the mouse brain these cells show FPR1 expression. These results suggest a role of the brain microenvironment in FPR1 expression in GBM.</p

    Early-life interventions to prevent feather pecking and reduce fearfulness in laying hens

    Get PDF
    Severe feather pecking, the pulling out of feathers of conspecifics, is a major welfare issue in laying hens. Possible underlying causes are fearfulness and lack of foraging opportunities. Because early life is a crucial stage in behavioral development, adapting the incubation and rearing environment to the birds' needs may reduce fearfulness and prevent the development of feather pecking. In a 2 × 2 factorial design study, we investigated whether a green light-dark cycle throughout incubation, which resembles natural incubation circumstances more than the standard dark incubation, and foraging enrichment with live larvae during rearing reduce fearfulness and feather pecking and increase foraging behavior of laying hen pullets from an early age onwards. In this 2-batch experiment, 1,100 ISA Brown eggs were incubated under either 0 h of light/24 h of darkness or 12 h of green LED light/12 h of darkness. After hatching, 400 female chicks (200 per batch) were housed in 44 pens (8–10 chicks per pen). During the entire rearing phase (0–17 wk of age), half of the pens received black soldier fly larvae in a food puzzle as foraging enrichment. We assessed fear of novel objects and humans, feather pecking, plumage condition, foraging behavior, and recovery time after a 3-fold vaccination (acute stressor). A slight increase in the number of foraging bouts was only seen with larvae provisioning (rate ratio 1.19, 95% CI 1.02–1.29, P = 0.008). Neither lighted incubation nor larvae provisioning affected fearfulness, feather pecking, plumage condition or recovery time after vaccination. In conclusion, the present study showed no effects of light during incubation and minor effects of foraging enrichment during rearing on the behavior of laying hen pullets. Further research is recommended on other welfare aspects

    Adjusted Light and Dark Cycles Can Optimize Photosynthetic Efficiency in Algae Growing in Photobioreactors

    Get PDF
    Biofuels from algae are highly interesting as renewable energy sources to replace, at least partially, fossil fuels, but great research efforts are still needed to optimize growth parameters to develop competitive large-scale cultivation systems. One factor with a seminal influence on productivity is light availability. Light energy fully supports algal growth, but it leads to oxidative stress if illumination is in excess. In this work, the influence of light intensity on the growth and lipid productivity of Nannochloropsis salina was investigated in a flat-bed photobioreactor designed to minimize cells self-shading. The influence of various light intensities was studied with both continuous illumination and alternation of light and dark cycles at various frequencies, which mimic illumination variations in a photobioreactor due to mixing. Results show that Nannochloropsis can efficiently exploit even very intense light, provided that dark cycles occur to allow for re-oxidation of the electron transporters of the photosynthetic apparatus. If alternation of light and dark is not optimal, algae undergo radiation damage and photosynthetic productivity is greatly reduced. Our results demonstrate that, in a photobioreactor for the cultivation of algae, optimizing mixing is essential in order to ensure that the algae exploit light energy efficiently

    The incidence and management of tolerance in intrathecal baclofen therapy

    No full text
    Study design: Retrospective study. Objectives: To study the incidence and management of tolerance in patients treated with intrathecal baclofen (ITB) therapy. Setting: Department of neurology and neurosurgery, University Medical Center Groningen, The Netherlands. Methods: Medical records of all patients who had received an implantable ITB pump at our clinic during 1991-2005 were reviewed. Results: A total of 37 patients (representing 116 pump years) were included. Mean follow-up time was 38 months (range 3-120 months). Baclofen dose increased in the first 18 months after implantation (P <0.05), and then stabilized around a mean dose of 350 mu g per day. Eight patients (22%) developed tolerance, defined as a dose increase of > 100 mu g per year. No predictive factors for development of tolerance could be determined. Three different treatment regimens for tolerant patients were analyzed. Altering the infusion mode from simple to complex continuous (n = 6) had no effect on the development of tolerance. Pulsatile bolus infusion (n = 1) and a drug holiday (n = 2) were both effective in reducing the daily baclofen dose. Patients who needed surgical revision of the pump system because of mechanical failures (n = 11) showed a significant dose decrease during the first month after revision, indicating that the preoperative dose increase most likely had been caused by the pump failure. Pump-related complications occurred once per 10.5 years of ITB treatment. Drug-related side effects had an annual risk of 13.8%. The reported events were mostly mild. Conclusions: ITB therapy is effective and safe, also in the long term and causes tolerance in only 22% of the treated patients. Spinal Cord (2009) 47, 751-756; doi: 10.1038/sc.2009.34; published online 31 March 200
    • …
    corecore